Last €15.69 EUR
Change Today +0.09 / 0.58%
Volume 0.0
58M On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:03 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

medassets inc (58M) Snapshot

Open
€15.68
Previous Close
€15.60
Day High
€15.69
Day Low
€15.68
52 Week High
03/24/14 - €18.60
52 Week Low
01/3/14 - €14.20
Market Cap
944.7M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
60.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDASSETS INC (58M)

medassets inc (58M) Related Bloomberg News

View More Bloomberg News

medassets inc (58M) Related Businessweek News

View More BusinessWeek News

medassets inc (58M) Details

MedAssets, Inc., a financial and performance improvement company, provides technology-enabled products and services for hospitals, health systems, and other ancillary healthcare providers in the United States. It operates in two segments, Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment provides a suite of cost management services, supply chain analytics, and data capabilities; strategic sourcing and group purchasing services; medical device and clinical resource consulting services; lean performance improvement services; workforce management; and supply chain outsourcing and procurement services. This segment is also involved in the provision of business intelligence and decision support tool services. The RCM segment offers a suite of software as a service or Web-based software and technology-enabled services, which address various revenue cycle processes comprising patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing, denials management and reimbursement integrity, payer contract management, extended business office revenue recovery, accounts receivable services, and outsourcing services. As of December 31, 2013, the company served approximately 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. MedAssets, Inc. was incorporated in 1999 and is headquartered in Alpharetta, Georgia.

3,200 Employees
Last Reported Date: 03/3/14
Founded in 1999

medassets inc (58M) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, M...
Total Annual Compensation: $1.4M
President, Chief Operating Officer and Direct...
Total Annual Compensation: $810.1K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $660.0K
President of Spend and Clinical Resource Mana...
Total Annual Compensation: $518.9K
Chief Customer Officer, Senior Executive Vice...
Total Annual Compensation: $727.2K
Compensation as of Fiscal Year 2013.

medassets inc (58M) Key Developments

MedAssets Promotes Mike Nolte to President, COO and Board of Directors

MedAssets announced that Mike Nolte, currently serves as executive vice president and chief operating officer, was promoted to president and COO and has been appointed to the company's board of directors, effective immediately. Mr. Nolte will continue to be responsible for leading the company's operating activities, working with senior management to drive performance excellence and financial results across all business lines. Mr. Nolte joined MedAssets in March 2012. He most recently served as vice president and general manager of the Americas Services business for GE Healthcare IT.

MedAssets, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 08:00 AM

MedAssets, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 08:00 AM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Robert P. Borchert, Senior Vice President of Investor & Corporate Communications.

MedAssets, Inc. Announces Strategic Partnership with Procured Health to Deliver Best-Practice Clinical Value Analysis Programs

MedAssets, Inc. announced a strategic partnership with Procured Health to deliver a holistic approach to implementing best-practice clinical value analysis programs. Under terms of the agreement, MedAssets will augment its clinical value analysis consulting and services with Procured Health's proprietary data intelligence and collaboration technology platform. The SaaS-based analytical tool and complementary purpose-built workflow solution provide hospital administrators and physicians unparalleled transparency into medical supply options and comparative safety and outcomes data. With improved market information and process oversight, hospitals are able to promote appropriate product utilization and optimize savings opportunities. Now, through MedAssets, organizations can adopt a holistic approach to proven value analysis models, expert services, and an analytics and product research platform to help improve evaluation and purchasing of high-expense physician preference items (PPI) and other medical/surgical supplies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
58M:GR €15.69 EUR +0.09

58M Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Accretive Health Inc $8.70 USD +0.10
AMN Healthcare Services Inc $19.89 USD +0.14
Huron Consulting Group Inc $68.33 USD -0.58
Navigant Consulting Inc $15.42 USD -0.16
Advisory Board Co/The $49.30 USD -0.58
View Industry Companies
 

Industry Analysis

58M

Industry Average

Valuation 58M Industry Range
Price/Earnings 39.8x
Price/Sales 1.7x
Price/Book 2.4x
Price/Cash Flow 8.8x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDASSETS INC, please visit www.medassets.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.